USP17L15
gene geneOn this page
Summary
USP17L15 (ubiquitin specific peptidase 17 like family member 15, HGNC:44443) is a protein-coding gene on chromosome 4p16.1, encoding Ubiquitin carboxyl-terminal hydrolase 17-like protein 15 (C9J2P7). Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection.
Predicted to enable cysteine-type deubiquitinase activity. Predicted to be involved in regulation of apoptotic process and regulation of protein stability. Predicted to be located in endoplasmic reticulum. Predicted to be active in cytosol and nucleus.
Source: NCBI Gene 100288520 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001256894
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44443 |
| Approved symbol | USP17L15 |
| Name | ubiquitin specific peptidase 17 like family member 15 |
| Location | 4p16.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000223569 |
| Ensembl biotype | protein_coding |
| Entrez | 100288520 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000456464
RefSeq mRNA: 1 — MANE Select: NM_001256894
NM_001256894
CCDS: CCDS77901
Canonical transcript exons
ENST00000456464 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001705928 | 9234385 | 9236046 |
Expression profiles
Bgee: expression breadth broad, 72 present calls, max score 78.61.
Top tissues by expression
105 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 78.61 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.54 | gold quality |
| monocyte | CL:0000576 | 50.54 | gold quality |
| right uterine tube | UBERON:0001302 | 49.99 | gold quality |
| leukocyte | CL:0000738 | 49.07 | gold quality |
| adrenal tissue | UBERON:0018303 | 45.93 | gold quality |
| primary visual cortex | UBERON:0002436 | 44.94 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 43.63 | silver quality |
| tonsil | UBERON:0002372 | 43.15 | gold quality |
| nucleus accumbens | UBERON:0001882 | 42.71 | gold quality |
| putamen | UBERON:0001874 | 42.27 | gold quality |
| caudate nucleus | UBERON:0001873 | 42.00 | gold quality |
| amygdala | UBERON:0001876 | 41.68 | gold quality |
| temporal lobe | UBERON:0001871 | 41.52 | gold quality |
| right frontal lobe | UBERON:0002810 | 41.44 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.42 | gold quality |
| fallopian tube | UBERON:0003889 | 41.37 | silver quality |
| pituitary gland | UBERON:0000007 | 41.34 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 41.01 | gold quality |
| urinary bladder | UBERON:0001255 | 40.96 | silver quality |
| Ammon’s horn | UBERON:0001954 | 40.84 | gold quality |
| bone marrow cell | CL:0002092 | 40.48 | gold quality |
| mucosa of stomach | UBERON:0001199 | 40.32 | silver quality |
| ventricular zone | UBERON:0003053 | 40.20 | gold quality |
| left uterine tube | UBERON:0001303 | 39.88 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 39.47 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.36 | gold quality |
| adenohypophysis | UBERON:0002196 | 39.21 | silver quality |
| muscle tissue | UBERON:0002385 | 39.08 | gold quality |
| hypothalamus | UBERON:0001898 | 38.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (71): USP2 (ENSG00000036672), USP28 (ENSG00000048028), USP36 (ENSG00000055483), USP13 (ENSG00000058056), USP33 (ENSG00000077254), USP40 (ENSG00000085982), USP48 (ENSG00000090686), USP14 (ENSG00000101557), USP11 (ENSG00000102226), USP10 (ENSG00000103194), USP31 (ENSG00000103404), USP42 (ENSG00000106346), USP5 (ENSG00000111667), USP4 (ENSG00000114316), USP9Y (ENSG00000114374), USP34 (ENSG00000115464), USP35 (ENSG00000118369), USP45 (ENSG00000123552), USP22 (ENSG00000124422), USP9X (ENSG00000124486), USP6 (ENSG00000129204), USP29 (ENSG00000131864), USP26 (ENSG00000134588), USP30 (ENSG00000135093), USP15 (ENSG00000135655), USP37 (ENSG00000135913), USP44 (ENSG00000136014), USP20 (ENSG00000136878), USP8 (ENSG00000138592), USP3 (ENSG00000140455), USP21 (ENSG00000143258), USP43 (ENSG00000154914), USP25 (ENSG00000155313), USP16 (ENSG00000156256), USP24 (ENSG00000162402), USP1 (ENSG00000162607), USP49 (ENSG00000164663), USP38 (ENSG00000170185), USP50 (ENSG00000170236), USP47 (ENSG00000170242)
Protein
Protein identifiers
Ubiquitin carboxyl-terminal hydrolase 17-like protein 15 — C9J2P7 (reviewed: C9J2P7)
All UniProt accessions (1): C9J2P7
UniProt curated annotations — full annotation on UniProt →
Function. Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection.
Subcellular location. Nucleus. Endoplasmic reticulum.
Similarity. Belongs to the peptidase C19 family. USP17 subfamily.
RefSeq proteins (1): NP_001243823* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001394 | Peptidase_C19_UCH | Domain |
| IPR018200 | USP_CS | Conserved_site |
| IPR028889 | USP | Domain |
| IPR038765 | Papain-like_cys_pep_sf | Homologous_superfamily |
| IPR050164 | Peptidase_C19 | Family |
Pfam: PF00443
UniProt features (10 total): compositionally biased region 4, region of interest 2, active site 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-C9J2P7-F1 | 66.37 | 0.43 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 89 (nucleophile); 334 (proton acceptor)
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5689880 | Ub-specific processing proteases |
MSigDB gene sets: 14 (showing top):
GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL, GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY, chr4p16, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, REACTOME_DEUBIQUITINATION, REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES, GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH, GOBP_PROTEIN_MODIFICATION_PROCESS, GOMF_DEUBIQUITINASE_ACTIVITY
GO Biological Process (4): proteolysis (GO:0006508), protein deubiquitination (GO:0016579), regulation of protein stability (GO:0031647), regulation of apoptotic process (GO:0042981)
GO Molecular Function (4): cysteine-type deubiquitinase activity (GO:0004843), peptidase activity (GO:0008233), cysteine-type peptidase activity (GO:0008234), hydrolase activity (GO:0016787)
GO Cellular Component (3): nucleus (GO:0005634), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Deubiquitination | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 2 |
| cytoplasm | 2 |
| protein metabolic process | 1 |
| cysteine-type deubiquitinase activity | 1 |
| protein modification by small protein removal | 1 |
| regulation of biological quality | 1 |
| apoptotic process | 1 |
| regulation of programmed cell death | 1 |
| cysteine-type peptidase activity | 1 |
| deubiquitinase activity | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| peptidase activity | 1 |
| catalytic activity | 1 |
| endomembrane system | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
108 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| USP17L15 | OR1J1 | Q8NGS3 | 590 |
| USP17L15 | FAM98B | Q52LJ0 | 506 |
| USP17L15 | METTL15 | A6NJ78 | 480 |
| USP17L15 | TASOR | Q9UK61 | 448 |
| USP17L15 | MRPS27 | Q92552 | 447 |
| USP17L15 | OR9Q1 | Q8NGQ5 | 432 |
| USP17L15 | OR1L8 | Q8NGR8 | 432 |
| USP17L15 | HEMGN | Q9BXL5 | 419 |
| USP17L15 | OR2T10 | Q8NGZ9 | 419 |
| USP17L15 | OR10V1 | Q8NGI7 | 398 |
| USP17L15 | SLC30A6 | Q6NXT4 | 391 |
| USP17L15 | OR2T11 | Q8NH01 | 370 |
| USP17L15 | OR52B6 | Q8NGF0 | 368 |
| USP17L15 | UPF3B | Q9BZI7 | 348 |
| USP17L15 | OR2A42 | Q8NGT9 | 322 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| M | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A2A5N8, A6NCW0, A6NCW7, A8MUK1, B1AQJ2, B2RQC2, C9J2P7, C9JJH3, C9JLJ4, C9JPN9, C9JVI0, D3ZWK4, D6R901, D6R9N7, D6RA61, D6RBM5, D6RBQ6, D6RCP7, D6RJB6, E9Q9U0, G5E8G2, G5E8I7, O94966, P0C7H9, P0C7I0, P35125, P51784, Q0E2F9, Q0WX57, Q2TAC6, Q3UJD6, Q4KLL9, Q5R7G8, Q5TKR9, Q61068, Q66HE5, Q6J1Y9, Q6PFD6, Q6QN14, Q6R6M4
Diamond homologs: A1L1K8, A6NCW0, A6NCW7, A8MUK1, C9J2P7, C9JJH3, C9JLJ4, C9JPN9, C9JVI0, D6R901, D6R9N7, D6RA61, D6RBQ6, D6RCP7, D6RJB6, G1SW77, P0C7H9, P0C7I0, Q0WX57, Q5JVS0, Q5XJA5, Q6AXS5, Q6NRY1, Q6PB22, Q6R6M4, Q7RTZ2, Q8NC51, Q9CY58, Q9I9R0, Q9JKS5, A0JM59, A5PMR2, A5PN09, A6H8I0, A6NNY8, A6QNM7, A7Z056, B1AY13, B1WBD7, D3ZJ96
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
44 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:9235676:A:T | donor_gain | 0.4600 |
| 4:9235675:G:GT | donor_gain | 0.4200 |
| 4:9234499:G:GC | acceptor_gain | 0.4000 |
| 4:9235749:CGAAG:C | donor_loss | 0.3900 |
| 4:9235750:GAAG:G | donor_loss | 0.3900 |
| 4:9235751:AAGGT:A | donor_loss | 0.3900 |
| 4:9235752:AGG:A | donor_loss | 0.3900 |
| 4:9235753:G:GT | donor_loss | 0.3900 |
| 4:9235754:G:GA | donor_loss | 0.3900 |
| 4:9235755:T:A | donor_loss | 0.3900 |
| 4:9235756:A:C | donor_loss | 0.3700 |
| 4:9235658:TGGA:T | donor_gain | 0.3500 |
| 4:9234592:C:CG | donor_gain | 0.3400 |
| 4:9235602:A:T | donor_gain | 0.3300 |
| 4:9234592:C:G | donor_gain | 0.3200 |
| 4:9234652:T:TA | acceptor_gain | 0.3200 |
| 4:9234653:A:AA | acceptor_gain | 0.3200 |
| 4:9235748:TCGA:T | donor_gain | 0.2900 |
| 4:9235483:GCC:G | donor_gain | 0.2800 |
| 4:9235989:G:GG | donor_gain | 0.2800 |
| 4:9234579:G:GT | donor_gain | 0.2700 |
| 4:9235161:G:C | acceptor_gain | 0.2700 |
| 4:9235780:A:AG | donor_gain | 0.2700 |
| 4:9235923:G:GT | donor_gain | 0.2700 |
| 4:9235877:A:T | donor_gain | 0.2500 |
| 4:9235986:G:GT | donor_gain | 0.2500 |
| 4:9235988:A:AG | donor_gain | 0.2500 |
| 4:9235502:T:G | acceptor_gain | 0.2400 |
| 4:9235588:C:T | donor_gain | 0.2400 |
| 4:9235893:C:T | donor_gain | 0.2400 |
AlphaMissense
3488 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1157273565 (4:9234828 A>T), RS1157314212 (4:9235625 G>T), RS1158294351 (4:9236060 C>G,T), RS1158567322 (4:9233632 A>G), RS1158911495 (4:9234149 C>A,T), RS1160891183 (4:9235560 A>T), RS1160983619 (4:9234568 C>G), RS1162769640 (4:9235914 G>A,C), RS1164013166 (4:9235242 C>G), RS1164574455 (4:9233977 C>A,G), RS1164675223 (4:9236368 G>C), RS1167359459 (4:9235377 C>T), RS1168131900 (4:9236099 C>T), RS1168472935 (4:9234282 C>A,T), RS1170149506 (4:9235531 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.